Home Alzheimer’s Disease Clinical Implications from the TAILORx Trial

Clinical Implications from the TAILORx Trial

Transcript:

 

Kristie L. Kahl: Can you provide a general overview of the TAILORx trial?

Jane L. Meisel, MD: It helps first to talk about what Onctotype is. Anyone who has studied estrogen-positive breast cancer or has had estrogen-positive breast cancer, probably will be familiar with Oncotype. Essentially it is a genomic test that takes a woman’s tumor after it has been removed and analyzes that tumor to look at levels of expression of different genes in the tumor. If you have high levels of expression of high-risk genes – genes that portend a poor prognosis or a high risk of recurrence – and your Oncotype score, which is a numerical score you get back, is higher. And if you have higher levels of low-risk genes, then your score will typically come back lower. That score is on a continuum. 

This is a test that has been validated for a long time. We’ve known for a long…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Cause of Alzheimer’s disease traced to mutation in common enzyme

submitted by /u/scotsman81 Continue Reading to the Source

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Recent Comments